Notably, despite low absolute neutrophil counts from standard-of-care RA DMARD therapy, the percent level of DEspR+CD11b+ neutrophils and NET+Ns are relatively high comparable to %levels seen in ARDS [9] and sICH [10]. The gene discussed is ITGAM; the disease is rheumatoid arthritis.